Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Clinical trial on the efficacy of an intervention package to improve adherence to treatment for systolic blood pressure (BP) reduction in primary care patients with poorly controlled or uncontrolled BP and low adherence to treatment
ISRCTN ISRCTN21229328
ClinicalTrials.gov identifier
Public title Clinical trial on the efficacy of an intervention package to improve adherence to treatment for systolic blood pressure (BP) reduction in primary care patients with poorly controlled or uncontrolled BP and low adherence to treatment
Scientific title A randomised controlled trial on the efficacy of a multifactorial intervention to improve adherence to treatment for systolic blood pressure (BP) reduction in primary care patients with poorly controlled or uncontrolled BP and low adherence to treatment
Acronym N/A
Serial number at source PS09/01456
Study hypothesis Background:
Lowering blood pressure (BP) with antihypertensive drugs has an important risk reduction effect on cardiovascular events, mainly stroke and total mortality. However lack of adherence to antihypertensive medication reduces its effectiveness and increases the risk for adverse effects to the medication. Improvement of patient adherence to the treatment could be similar in relative risk reduction than the development of a new drug.

Hypotheses:
1. In primary care patients with poorly- or un-controlled BP and low adherence to treatment, a 9-month multifactorial intervention with the aim of improving communication between medical staff and patient and thus facilitating the taking of medication will result in decreased systolic blood pressure (SBP) at 12 months compared with patients in the control group
2. The estimated direct cost at 12 months resulting from the use of health services associated with hypertension in the intervention group will be at least 10% lower than the control group
3. The number needed to treat (NNT) will be 10 - 15
Lay summary
Ethics approval The Ethical Committee on Human Reseach of Balearic Islands approved on the 26th May 2010
Study design Cluster randomised controlled trial
Countries of recruitment Spain
Disease/condition/study domain Non-optimally controlled hypertension
Participants - inclusion criteria 1. Patients between 18 and 80 years of age
2. Non controlled BP according to European Societies of Hypertension and Cardiology (ESH/ESC) guidelines (i.e. BP less than 140/90 mmHg or less than 130/80 mmHg in diabetic or renal failure patients)
3. Adherence below 80% to AHT by Hayness-Sacket Test
Participants - exclusion criteria 1. Non-essential hypertensive patients
2. Haemodialysis patients
3. Institutionalised patients
Anticipated start date 15/10/2010
Anticipated end date 15/12/2012
Status of trial Ongoing
Patient information material Not available in web format, please contact Mr Alfonso Leiva Rus [aleiva@ibsalut.caib.es] to request a patient information sheet
Target number of participants 309 randomised patients from primary care centres in Spain
Interventions Patients in the intervention group will attend of 3 sessions consisting of a 30 minute semi-structured motivational interview and a 15-minute health education programme combined with simplifying dosing regimens, family and/or social support, blood pressure self-monitoring and use of medication reminders.

Patients in the control group will receive treatment as usual.

The duration of the intervention will be 6 months. The total duration of follow-up will be 12 months.
Primary outcome measure(s) Change in systolic BP at 12 months
Secondary outcome measure(s) 1. Change in diastolic BP
2. Proportion of participants with adequate BP control at 12 months
3. Total direct cost
Sources of funding Health Research Fund (Fondo de Investigaciones Sanitarias [FIS]) (Spain)
Trial website
Publications 1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20868531
Contact name Miss  Lucia  Moreno
  Address Gerencia de Atención Primaria
C/ Reina Esclaramunda nº 9
  City/town Palma de Mallorca
  Zip/Postcode 07003
  Country Spain
  Email lmoreno@ibsalut.caib.es
Sponsor Health Service of the Balearic Islands (Servei de Salut de les Illes Balears [IB-salut]) (Spain)
  Address Mallorca Primary Care Management
C/ Reina Esclaramunda nº 9
  City/town Palma de Mallorca
  Zip/Postcode 07003
  Country Spain
  Tel +34 (0)971 175883
  Fax +34 (0)971 175888
  Email aleiva@ibsalut.caib.es
Date applied 17/06/2010
Last edited 26/05/2011
Date ISRCTN assigned 27/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central